The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting
- PMID: 11574355
- DOI: 10.1097/00000539-200110000-00021
The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting
Abstract
Dolasetron (12.5 mg IV) is effective in both preventing and treating postoperative nausea and vomiting (PONV) after ambulatory surgery. However, the optimal timing of dolasetron administration and its effect on the patient's quality of life after discharge have not been established. One-hundred-five healthy, consenting women undergoing gynecologic laparoscopic procedures with a standardized general anesthetic technique were enrolled in this randomized, double-blinded study. Group 1 received dolasetron 12.5 mg IV 10-15 min before the induction of anesthesia; Group 2 received dolasetron 12.5 mg IV at the end of the laparoscopy (79 +/- 48 min later than Group 1); and Group 3 received dolasetron 12.5 mg IV at the end of anesthesia (93 +/- 52 min later than Group 1). The incidence of PONV, complete responses (defined as no emetic episodes and no rescue medication within the 24-h period after anesthesia), recovery profiles, and patient satisfaction were recorded. In the postanesthesia care unit and during the 24-h follow-up period, the incidence of nausea and vomiting, as well as the need for rescue antiemetics, did not differ significantly among the three groups. The percentages of patients with complete responses to the study drug within the first postoperative 24 h were also similar in all three groups (55%, 59%, and 52% for Groups 1, 2, and 3, respectively). The early and intermediate recovery profiles, including resumption of a normal diet and patient satisfaction with the control of PONV, were not different among the three study groups. Dolasetron 12.5 mg IV administered before the induction of anesthesia is as effective as dolasetron given at the end of laparoscopy or at the end of anesthesia in preventing PONV after outpatient laparoscopy.
Implications: The timing of dolasetron administration appears to have little effect on its efficacy when administered as a prophylactic antiemetic in the ambulatory setting.
Similar articles
-
A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.Anesth Analg. 2000 Jun;90(6):1352-8. doi: 10.1097/00000539-200006000-00017. Anesth Analg. 2000. PMID: 10825320 Clinical Trial.
-
Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.Anesth Analg. 2002 Nov;95(5):1230-5, table of contents. doi: 10.1097/00000539-200211000-00021. Anesth Analg. 2002. PMID: 12401599 Clinical Trial.
-
Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery.Anesth Analg. 1997 Feb;84(2):325-30. doi: 10.1097/00000539-199702000-00015. Anesth Analg. 1997. PMID: 9024022 Clinical Trial.
-
Management of postoperative nausea and vomiting in ambulatory surgery.Anesthesiol Clin North Am. 2003 Jun;21(2):347-65. doi: 10.1016/s0889-8537(03)00017-8. Anesthesiol Clin North Am. 2003. PMID: 12812400 Review.
-
Anesthesia for laparoscopy with emphasis on outpatient laparoscopy.Anesthesiol Clin North Am. 2001 Mar;19(1):21-41. doi: 10.1016/s0889-8537(05)70209-1. Anesthesiol Clin North Am. 2001. PMID: 11244918 Review.
Cited by
-
[Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].Anaesthesist. 2007 Nov;56(11):1170-80. doi: 10.1007/s00101-007-1210-0. Anaesthesist. 2007. PMID: 17726590 Review. German.
-
Prophylactic antiemetic effects of Midazolam, Ondansetron, and their combination after middle ear surgery.J Res Pharm Pract. 2016 Jan-Mar;5(1):16-21. doi: 10.4103/2279-042X.176556. J Res Pharm Pract. 2016. PMID: 26985431 Free PMC article.
-
Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial.Yonsei Med J. 2012 Nov 1;53(6):1197-202. doi: 10.3349/ymj.2012.53.6.1197. Yonsei Med J. 2012. PMID: 23074122 Free PMC article. Clinical Trial.
-
Drugs for preventing postoperative nausea and vomiting.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD004125. doi: 10.1002/14651858.CD004125.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2017 Jul 17;7:CD004125. doi: 10.1002/14651858.CD004125.pub3. PMID: 16856030 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources